Selection criteria | |
Inclusion | |
(1) Topic of study: human cancer | |
(2) Diagnosis method: pathology or histology | |
(3) Detected method of SNHG16: qRT-PCR, ISH, or other methods in tissues | |
(4) Patients divided into “high SNHG16” and “low SNHG16” groups | |
(5) Association between SNHG16 and clinicopathological and prognostic featuresa: clearly reported | |
(6) HR and 95% CIs: acquired or estimated | |
Exclusion | |
(1) Literature type: reviews, case reports, meeting abstracts, and basic experimental research literature | |
(2) Duplicate articles or data | |
(3) Publication language: other than English |